Page 2 - Nasdaq Lab News Today

Standard BioTools Inc. (NASDAQ:LAB – Get Rating) CFO Jeffrey G. Black acquired 43,492 shares of the firm’s stock in a transaction on Thursday, May 18th. The shares were purchased at an average cost of $2.22 per share, for a total transaction of $96,552.24. Following the completion of the purchase, the chief financial officer now directly […]

Standard BioTools Inc. (NASDAQ:LAB – Get Rating) CFO Jeffrey G. Black bought 43,492 shares of the firm’s stock in a transaction dated Thursday, May 18th. The shares were bought at an average price of $2.22 per share, with a total value of $96,552.24. Following the completion of the transaction, the chief financial officer now directly […]

Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period...

Standard BioTools (NASDAQ:LAB – Get Rating) and Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Earnings & Valuation This table compares Standard BioTools and […]

Susquehanna International Group LLP raised its position in shares of Standard BioTools Inc. (NASDAQ:LAB – Get Rating) by 189.5% in the fourth quarter, Holdings Channel reports. The fund owned 43,137 shares of the company’s stock after buying an additional 28,237 shares during the quarter. Susquehanna International Group LLP’s holdings in Standard BioTools were worth $50,000 […]

Standard BioTools Inc. (NASDAQ:LAB – Get Rating) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 2,600,000 shares, a decrease of 15.0% from the February 28th total of 3,060,000 shares. Based on an average daily trading volume, of 246,200 shares, […]

Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP...

Standard BioTools (NASDAQ:LAB – Get Rating) and Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends. Profitability This table compares Standard BioTools and Olink […]

Standard BioTools (NASDAQ:LAB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Standard BioTools to related companies based on the strength of its profitability, earnings, analyst recommendations, risk, dividends, valuation and institutional ownership. Profitability This table compares […]

Standard BioTools (NASDAQ:LAB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Standard BioTools to related businesses based on the strength of its earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Analyst Recommendations This is […]